We'll never know how the experts who reviewed the JAMA article may have changed it, but frankly it played right into the hands of the AdamF's etc. If the Journal had simply explained that PFS was dropped as a goal because of pseudoprogression, and explained it, but provided no K-M plots etc. guys like AdamF, H-G, and others here would have had nothing to discuss. Unfortunately they were displayed, they gave the impression that progression occurred sooner for those who received the vaccine. Sure it was actually pseudoprogression, but no attempt was made to display it that way, it simply provided all that was needed to create doubt.
NWBO just seems to be snakebit at times, Dr. Liau's Covid at NYAS is just another example, regardless of how well the presentation was given, the allegation that Dr. Liau was ducking the presentation killed the benefit before it ever started. AdamF no doubt would have brought up the K-M's for PFS, but Dr. Liau may have taken that on in her presentation or during the Q&A, but she wasn't there to do so.
AdamF had good sources, he learned of Dr. Liau's illness before investors knew of it, frankly I don't know if the company knew it, or not, at the time AdamF went public with the allegation that Dr. Liau was well in England, but was ducking the presentation of a failed trial. You can't be much more creative than AdamF was in working to bring down a stock. Don't get me wrong, AdamF has gone after many stocks, he's been a tool of the shorts for many companies, not just NWBO, but even he must consider NWBO a crowning achievement for him, at least to date. When NWBO is trading for 10 to 100 times what it is today, no one will think of it as AdamF's failure.
Gary
News 
Market Data 
Discover 
AI
